Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Ruijtenbeek

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Cancers|October 17, 2020
Erratum: Krayem, M., et al. Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance Short Title: Sensitivity Prediction to MAPK Inhibitors in Melanoma. <i>Cancers</i> 2020, <i>12</i>, 512Mohammad Krayem, Philippe Aftimos, Ahmad Najem, et al.
Leukemia & Lymphoma|December 8, 2010
Identification of new possible targets for leukemia treatment by kinase activity profilingArja Ter Elst, Sander H Diks, Kim R Kampen, et al.
Molecular Pharmaceutics|May 12, 2017
Cetuximab Prevents Methotrexate-Induced Cytotoxicity in Vitro through Epidermal Growth Factor Dependent Regulation of Renal Drug TransportersPedro Caetano-Pinto, Amer Jamalpoor, Janneke Ham, et al.
Cancer Research|July 2, 2009
Kinome profiling in pediatric brain tumors as a new approach for target discoveryArend H Sikkema, Sander H Diks, Wilfred F A den Dunnen, et al.
Journal of Cellular Physiology|January 22, 2020
Crizotinib sensitizes the erlotinib resistant HCC827GR5 cell line by influencing lysosomal functionNele Van Der Steen, Kaylee Keller, Henk Dekker, et al.
Nature Communications|June 27, 2020
Chemical genetics strategy to profile kinase target engagement reveals role of FES in neutrophil phagocytosisTom van der Wel, Riet Hilhorst, Hans den Dulk, et al.
Clinical Proteomics|February 19, 2021
Time dependent effect of cold ischemia on the phosphoproteome and protein kinase activity in fresh-frozen colorectal cancer tissue obtained from patientsTineke E Buffart, Rosanne A H M van den Oord, Adriënne van den Berg, et al.
Cancers|June 24, 2022
Genome-Wide Meta-Analysis Identifies Variants in <i>DSCAM</i> and <i>PDLIM3</i> That Correlate with Efficacy Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with SunitinibMeta H M Diekstra, Jesse J Swen, Loes F M van der Zanden, et al.
Journal for Immunotherapy of Cancer|January 11, 2021
Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancerDaan P Hurkmans, Els M E Verdegaal, Sabrina A Hogan, et al.
Nature Biotechnology|September 29, 2021
A public-private partnership model for COVID-19 diagnosticsPeter H L Krijger, Tim A Hoek, Sanne Boersma, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Cancers|October 17, 2020
Erratum: Krayem, M., et al. Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance Short Title: Sensitivity Prediction to MAPK Inhibitors in Melanoma. <i>Cancers</i> 2020, <i>12</i>, 512Mohammad Krayem, Philippe Aftimos, Ahmad Najem, et al.
Leukemia & Lymphoma|December 8, 2010
Identification of new possible targets for leukemia treatment by kinase activity profilingArja Ter Elst, Sander H Diks, Kim R Kampen, et al.
Molecular Pharmaceutics|May 12, 2017
Cetuximab Prevents Methotrexate-Induced Cytotoxicity in Vitro through Epidermal Growth Factor Dependent Regulation of Renal Drug TransportersPedro Caetano-Pinto, Amer Jamalpoor, Janneke Ham, et al.
Cancer Research|July 2, 2009
Kinome profiling in pediatric brain tumors as a new approach for target discoveryArend H Sikkema, Sander H Diks, Wilfred F A den Dunnen, et al.
Journal of Cellular Physiology|January 22, 2020
Crizotinib sensitizes the erlotinib resistant HCC827GR5 cell line by influencing lysosomal functionNele Van Der Steen, Kaylee Keller, Henk Dekker, et al.
Nature Communications|June 27, 2020
Chemical genetics strategy to profile kinase target engagement reveals role of FES in neutrophil phagocytosisTom van der Wel, Riet Hilhorst, Hans den Dulk, et al.
Clinical Proteomics|February 19, 2021
Time dependent effect of cold ischemia on the phosphoproteome and protein kinase activity in fresh-frozen colorectal cancer tissue obtained from patientsTineke E Buffart, Rosanne A H M van den Oord, Adriënne van den Berg, et al.
Cancers|June 24, 2022
Genome-Wide Meta-Analysis Identifies Variants in <i>DSCAM</i> and <i>PDLIM3</i> That Correlate with Efficacy Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with SunitinibMeta H M Diekstra, Jesse J Swen, Loes F M van der Zanden, et al.
Journal for Immunotherapy of Cancer|January 11, 2021
Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancerDaan P Hurkmans, Els M E Verdegaal, Sabrina A Hogan, et al.
Nature Biotechnology|September 29, 2021
A public-private partnership model for COVID-19 diagnosticsPeter H L Krijger, Tim A Hoek, Sanne Boersma, et al.
Pageof 7